Q1 2019 Holdings
Filed 2019-05-14 | 49 holdings | $432.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $240.9M | 2,046,832 | 55.7% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $76.8M | 3,375,169 | 17.8% |
| Codexis, Inc(CDXS) | Common | 192005106 | $53.8M | 2,618,951 | 12.4% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $42.7M | 2,328,475 | 9.9% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $9.9M | 1,647,214 | 2.3% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $7.9M | 1,213,290 | 1.8% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $38.9K | 1,359,149 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Insmed Inc(INSM) | Common Par | 457669307 | $34.0K | 1,170,290 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $33.3K | 12,606,605 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $32.2K | 1,159,742 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $31.5K | 4,011,236 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $29.5K | 781,185 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $27.3K | 2,056,000 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $26.0K | 504,980 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $25.0K | 1,791,257 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | Common | 60468T105 | $18.4K | 251,107 | 0.0% |
| MEI Pharma Inc | Common | 55279B202 | $17.7K | 5,778,106 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $15.2K | 843,478 | 0.0% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common | 462260100 | $15.2K | 1,600,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $14.3K | 1,405,476 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | Common | 00444P108 | $14.1K | 579,051 | 0.0% |
| Obseva SA | Common | H5861P103 | $12.0K | 937,147 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $11.7K | 5,575,785 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $10.8K | 180,336 | 0.0% |
| Nabriva Therapeutics AG | SHS | G63637105 | $10.7K | 4,403,687 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $10.0K | 620,134 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $9.7K | 1,492,951 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $9.5K | 700,000 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $9.0K | 4,359,683 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $8.6K | 1,043,020 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $8.6K | 481,609 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $7.9K | 971,337 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $7.5K | 383,538 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $7.4K | 6,818,181 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $5.8K | 105,000 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $5.0K | 280,511 | 0.0% |
| Genocea Biosciences Inc | Common | 372427104 | $4.6K | 7,811,206 | 0.0% |
| Strongbridge Biopharma plc | SHS USD | G85347105 | $4.6K | 914,062 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $4.2K | 2,438,270 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $2.3K | 1,513,975 | 0.0% |
| Zai Lab Limited(ZLAB) | ADR | 98887Q104 | $2.1K | 71,595 | 0.0% |
| DBV Technologies S.A. | ADR | 23306J101 | $2.1K | 269,995 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $1.9K | 1,233,677 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $1.4K | 16,128,515 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | Common | 816212104 | $1.3K | 546,054 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $1.2K | 345,850 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | $121 | 99,441 | 0.0% |
| Soleno Therapeutics, Inc. - Warrant | Warrant | 834203135 | $28 | 188,772 | 0.0% |